| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 179.41B | 179.92B | 171.34B | 174.36B | 117.54B | 107.65B |
| Gross Profit | 75.71B | 75.29B | 66.89B | 71.45B | 46.99B | 39.90B |
| EBITDA | 37.18B | 43.78B | 39.16B | 42.15B | 25.84B | 21.51B |
| Net Income | 15.54B | 15.72B | 13.97B | 15.03B | 8.98B | 7.28B |
Balance Sheet | ||||||
| Total Assets | 467.91B | 463.64B | 411.41B | 379.89B | 348.56B | 324.20B |
| Cash, Cash Equivalents and Short-Term Investments | 104.78B | 105.53B | 105.18B | 93.66B | 81.70B | 68.52B |
| Total Debt | 18.19B | 19.01B | 15.52B | 17.04B | 18.80B | 19.34B |
| Total Liabilities | 110.06B | 109.31B | 95.17B | 96.71B | 87.43B | 80.06B |
| Stockholders Equity | 270.49B | 264.64B | 236.45B | 212.62B | 200.76B | 190.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 25.37B | 17.72B | 22.82B | 7.16B | -1.59B |
| Operating Cash Flow | 0.00 | 33.65B | 22.08B | 27.32B | 14.48B | 1.77B |
| Investing Cash Flow | 0.00 | -17.47B | -9.80B | -7.82B | -17.86B | -7.80B |
| Financing Cash Flow | 0.00 | -4.62B | -7.54B | -6.60B | -3.40B | 5.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥426.78B | 15.93 | ― | 0.33% | 6.38% | 38.69% | |
69 Neutral | ¥1.44T | 28.41 | 11.19% | 1.12% | 10.99% | 2.35% | |
66 Neutral | ¥549.40B | 28.18 | ― | 1.12% | 5.90% | 17.39% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥26.35B | 124.21 | ― | 1.11% | -4.66% | -56.66% | |
49 Neutral | ¥55.42B | 6.12 | 4.10% | 4.16% | 11.52% | 162.04% | |
46 Neutral | ¥161.23B | 52.66 | ― | 0.26% | 14.49% | ― |